Literature DB >> 23956714

N-acetylcysteine instead of theophylline in patients with COPD who are candidates for elective off-pump CABG surgery: Is it possible in cardiovascular surgery unit?

Seyed Jalil Mirhosseini1, Seyed Khalil Forouzannia, Marjan Nasirian, Sadegh Ali-Hassan-Sayegh.   

Abstract

BACKGROUND: Forced expiratory volume in one second (FEV1) is a good predictor of chronic obstructive pulmonary disease (COPD). COPD is characterized by a chronic limitation of airflow. This study was designed to compare the effects and complications of theophylline alone, N-acetylcysteine (NAC) alone, and a combination of the two drugs on the rates of FEV1 in patients with COPD who were candidates for off-pump coronary artery bypass graft (CABG) surgery.
METHODS: This clinical trial was performed on 100 patients who had a smoking history of 27 pack years with a range of 20 to 40 pack years but were not heavy smokers and were candidates for elective off-pump CABG surgery in Afshar Cardiovascular Hospital, Yazd, Iran. The patients with a history of asthma and bronchospasm and non-COPD respiratory disorders were excluded. There were three groups, that is, the theophylline group (n=33) that received theophylline 10 mg/kg TDS after consumption of food, NAC group (n=33) who received NAC 10-15 mg/kg BD after consumption of food, and the combined group (n=32) who received theophylline and NAC together. Data were analyzed by analysis of variance (ANOVA), Chi-square, and exact test for quantitative and qualitative variables.
RESULTS: One hundred patients with COPD enrolled in this study as possible candidates for CABG surgery. Average age of the patients was 60.36±10.21 years. Of the participants, 83 (83.3%) were male and 17 (17%) were female. Rate of postoperative FEV1 to basal FEV1 was 0.76±0.32, 0.66±0.22, and 0.69±0.24 in the treatments with theophylline, NAC, and the combination, respectively. Theophylline, NAC, and a combination of these drugs can decrease the rate of postoperative FEV1 compared to basal FEV1 significantly. (P=0.0001).
CONCLUSION: Theophylline alone, NAC alone, and a combination of these drugs improve pulmonary function, and there are no significant differences between these protocols. Stomach discomfort and cardiac complications in treatment with theophylline alone is significantly higher than NAC alone and the combination.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; N-acetylcysteine; elective off-pump coronary artery bypass graft; theophylline

Year:  2013        PMID: 23956714      PMCID: PMC3737690          DOI: 10.4103/1658-354X.114069

Source DB:  PubMed          Journal:  Saudi J Anaesth


  17 in total

Review 1.  N-acetylcysteine: multiple clinical applications.

Authors:  Paul J Millea
Journal:  Am Fam Physician       Date:  2009-08-01       Impact factor: 3.292

2.  Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease.

Authors:  P Thomas; J A Pugsley; J H Stewart
Journal:  Chest       Date:  1992-01       Impact factor: 9.410

Review 3.  N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.

Authors:  Anna M Sadowska
Journal:  Ther Adv Respir Dis       Date:  2012-02-23       Impact factor: 4.031

4.  [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease].

Authors:  Chang-Hui Wang; Qian Zhang; Ming Li; Pei-Fang Fu; Zheng-Mao Yan; Ai-Mei Peng; Guo-Liang Zhang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2010-03-02

Review 5.  Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review.

Authors:  N S Dhalla; L Golfman; S Takeda; N Takeda; M Nagano
Journal:  Can J Cardiol       Date:  1999-05       Impact factor: 5.223

6.  [Theophylline in the treatment of chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study].

Authors:  Yu-min Zhou; Xiao-ping Wang; Xiang-yi Zeng; Rong Qiu; Jun-fen Xie; Sheng-ming Liu; Jin-ping Zheng; Nan-shan Zhong; Pi-xin Ran
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2006-09

7.  Effect of theophylline on the rate of moderate to severe exacerbations among patients with chronic obstructive pulmonary disease.

Authors:  Marie-Christyne Cyr; Marie-France Beauchesne; Catherine Lemière; Lucie Blais
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

Review 8.  [Medical maintenance treatment of chronic obstructive pulmonary disease (COPD)].

Authors:  H A M Kerstjens; D S Postma
Journal:  Ned Tijdschr Geneeskd       Date:  2002-08-31

9.  Beneficial effects of N-acetylcysteine and cysteine in stunned myocardium in perfused rat heart.

Authors:  L D Tang; J Z Sun; K Wu; C P Sun; Z M Tang
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

Review 10.  Epidemiology of chronic obstructive pulmonary disease: a literature review.

Authors:  Catherine E Rycroft; Anne Heyes; Lee Lanza; Karin Becker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-20
View more
  2 in total

1.  Erratum: N-acetylcysteine instead of theophylline in patients with COPD who are candidates for elective off-pump CABG surgery: Is it possible in cardiovascular surgery unit?

Authors: 
Journal:  Saudi J Anaesth       Date:  2017 Jul-Sep

2.  Electro-catalytic amplified sensor for determination of N-acetylcysteine in the presence of theophylline confirmed by experimental coupled theoretical investigation.

Authors:  Mohsen Keyvanfard; Hassan Karimi-Maleh; Fatemeh Karimi; Francis Opoku; Ephraim Muriithi Kiarii; Poomani Penny Govender; Mehdi Taghavi; Li Fu; Aysenur Aygun; Fatih Sen
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.